US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Mondelēz Global LLC Conducts U.S. Voluntary Recall of Four Carton Sizes of RITZ Peanut Butter Cracker Sandwiches Due to Labeling Error

      Summary Company Announcement Date: July 08, 2025 FDA Publish Date: July … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / B. Braun's Supplier Recall of Heparin API Prompts Voluntary Recall of Heparin Solutions (March 21)

B. Braun's Supplier Recall of Heparin API Prompts Voluntary Recall of Heparin Solutions (March 21)

March 22, 2008 By The FDA Leave a Comment

CONTACT: STEPHANIE EULER, 908-276-4344 EXT. 213 SUSAN DENBY, 610-997-4856

FOR IMMEDIATE RELEASE –IRVINE, CA — MARCH 21, 2008 — B. BRAUN MEDICAL INC. WAS RECENTLY NOTIFIED BY ITS SUPPLIER, SCIENTIFIC PROTEIN LABORATORIES LLC (SPL) OF A NATIONWIDE RECALL OF HEPARIN SODIUM USP ACTIVE PHARMACEUTICAL INGREDIENT (API). THE VOLUNTARY RECALL AFFECTS THE FOLLOWING 23 FINISHED PRODUCT (FP) LOTS MANUFACTURED AND DISTRIBUTED BY B. BRAUN MEDICAL INC. NATIONWIDE AND TO CANADA.

B. BRAUN FP LOT #

B. BRAUN FP MATERIAL

DESCRIPTION

NDC NUMBERS

CAN DIN

J7D490

P5872

HEPARIN SODIUM 25,000 UNITS IN 5% DEXTROSE INJECTION (250ML)

0264-9587-20

N/A

J7C684

P5771

HEPARIN SODIUM 25,000 UNITS IN 5% DEXTROSE INJECTION (500ML)

0264-9577-10

N/A

J7D496

P5771

HEPARIN SODIUM 25,000 UNITS IN 5% DEXTROSE INJECTION (500ML)

0264-9577-10

N/A

J7C470

P5872

HEPARIN SODIUM 25,000 UNITS IN 5% DEXTROSE INJECTION (250ML)

0264-9587-20

N/A

J7D580

P5671-00

HEPARIN SODIUM 20,000 UNITS IN 5% DEXTROSE INJECTION (500ML)

N/A

02209713

J7E420

P5872-00

HEPARIN SODIUM 25,000 UNITS IN 5% DEXTROSE INJECTION (250ML)

N/A

02209721

J7C611

P8721

HEPARIN SODIUM 1000 UNITS IN 0.9% SODIUM CHLORIDE INJECTION (500ML)

0264-9872-10

01935933

J7C557

P8721

HEPARIN SODIUM 1000 UNITS IN 0.9% SODIUM CHLORIDE INJECTION (500ML)

0264-9872-10

01935933

J7C477

P8721

HEPARIN SODIUM 1000 UNITS IN 0.9% SODIUM CHLORIDE INJECTION (500ML)

0264-9872-10

01935933

J7C705

P8721

HEPARIN SODIUM 1000 UNITS IN 0.9% SODIUM CHLORIDE INJECTION (500ML)

0264-9872-10

01935933

J7D485

P8721

HEPARIN SODIUM 1000 UNITS IN 0.9% SODIUM CHLORIDE INJECTION (500ML)

0264-9872-10

01935933

J7E415

P8721

HEPARIN SODIUM 1000 UNITS IN 0.9% SODIUM CHLORIDE INJECTION (500ML)

0264-9872-10

01935933

J7E416

P8721

HEPARIN SODIUM 1000 UNITS IN 0.9% SODIUM CHLORIDE INJECTION (500ML)

0264-9872-10

01935933

J7E494

P5872

HEPARIN SODIUM 25,000 UNITS IN 5% DEXTROSE INJECTION (250ML)

0264-9587-20

N/A

J7E500

P5771

HEPARIN SODIUM 25,000 UNITS IN 5% DEXTROSE INJECTION (500ML)

0264-9577-10

N/A

J7E577

P5771-00

HEPARIN SODIUM 25,000 UNITS IN 5% DEXTROSE INJECTION (500ML)

N/A

01935941

J7E489

P8721

HEPARIN SODIUM 1000 UNITS IN 0.9% SODIUM CHLORIDE INJECTION (500ML)

0264-9872-10

01935933

J7N556

P5872

HEPARIN SODIUM 25,000 UNITS IN 5% DEXTROSE INJECTION (250ML)

0264-9587-20

N/A

J7P404

P5771

HEPARIN SODIUM 25,000 U
NITS IN 5% DEXTROSE INJECTION (500ML)

0264-9577-10

N/A

J7N604

P5771

HEPARIN SODIUM 25,000 UNITS IN 5% DEXTROSE INJECTION (500ML)

0264-9577-10

N/A

J7P476

P5872

HEPARIN SODIUM 25,000 UNITS IN 5% DEXTROSE INJECTION (250ML)

0264-9587-20

N/A

J7N519

P8721

HEPARIN SODIUM 1000 UNITS IN 0.9% SODIUM CHLORIDE INJECTION (500ML)

0264-9872-10

01935933

J7N676

P8721

HEPARIN SODIUM 1000 UNITS IN 0.9% SODIUM CHLORIDE INJECTION (500ML)

0264-9872-10

01935933

B. BRAUN MEDICAL INC. BEGAN RECALLING THE LOTS ON MARCH 21, 2008 AS A PRECAUTIONARY MEASURE. THIS PRODUCT RECALL WAS INITIATED DUE TO A NOTIFICATION RECEIVED FROM THE SUPPLIER, SCIENTIFIC PROTEIN LABORATORIES (SPL), DISCLOSING THAT ONE LOT OF HEPARIN SODIUM, USP ACTIVE PHARMACEUTICAL INGREDIENT ACQUIRED BY B. BRAUN MEDICAL INC. HAS A HEPARIN-LIKE CONTAMINANT. TO DATE, B. BRAUN MEDICAL INC. HAS NOT RECEIVED ANY ADVERSE EVENT REPORTS RELATED TO THIS ISSUE.

THE FOOD AND DRUG ADMINISTRATION HAS RECEIVED REPORTS OF SERIOUS INJURIES AND/OR DEATHS IN PATIENTS WHO HAVE BEEN ADMINISTERED HEPARIN INJECTABLE PRODUCTS OF OTHER COMPANIES CONTAINING THIS CONTAMINANT. AS INDICATED IN THE NOTIFICATION ISSUED BY THE SUPPLIER SPL, TYPICAL SYMPTOMS INCLUDE ANAPHYLACTIC-LIKE REACTIONS SUCH AS LOW BLOOD PRESSURE, SHORTNESS OF BREATH, NAUSEA, VOMITING, DIARRHEA AND ABDOMINAL PAIN.

ADVERSE REACTIONS OR QUALITY PROBLEMS EXPERIENCED IN THE U.S. WITH THE USE OF THIS PRODUCT MAY BE REPORTED TO THE FDA’S MEDWATCH ADVERSE EVENT REPORTING PROGRAM EITHER ONLINE, BY REGULAR MAIL OR BY FAX.

ONLINE: WWW.FDA.GOV/MEDWATCH/REPORT.HTM REGULAR MAIL: USE POSTAGE-PAID FDA FORM 3500 AVAILABLE AT: WWW.FDA.GOV/MEDWATCH/GETFORMS.HTM. MAIL TO MEDWATCH 5600 FISHERS LANE, ROCKVILLE, MD 20852-9787 FAX: 1-800-FDA-0178 

ADVERSE REACTIONS OR QUALITY PROBLEMS EXPERIENCED IN CANADA WITH USE OF THIS PRODUCT MAY BE REPORTED TO HEALTH CANADA.  FOR DETAILS ON HOW TO REPORT THESE REACTIONS PLEASE REFER TO THE FOLLOWING WEBSITE:

ONLINE: HTTP://WWW.HC-SC.GC.CA/DHP-MPS/MEDEFF/REPORT-DECLARATION/INDEX_E.HTML

CUSTOMERS WHO HAVE PRODUCT IN THEIR POSSESSION FROM THE RECALLED PRODUCT LOTS SHOULD DISCONTINUE USE IMMEDIATELY.  PATIENTS REPORTING ANY PROBLEMS THAT MAY BE RELATED TO THE USE OF THIS PRODUCT SHOULD BE ADVISED TO CONTACT A PHYSICIAN. CUSTOMERS MAY CONTACT B. BRAUN MEDICAL INC. CUSTOMER SUPPORT DEPARTMENT AT (800) 227-2862 FOR U.S. AND (800) 624-2920 FOR CANADA, MONDAY THROUGH FRIDAY, 8 AM TO 7 PM EST FOR INSTRUCTIONS FOR HANDLING THE AFFECTED PRODUCT AND TO ARRANGE FOR REPLACEMENT PRODUCT.

 

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Mondelēz Global LLC Conducts U.S. Voluntary Recall of Four Carton Sizes of RITZ Peanut Butter Cracker Sandwiches Due to Labeling Error

July 8, 2025 By The FDA

509 Recalls Helmets Due to Risk of Head Injury

July 2, 2025 By The CPSC

SNLN Party Supply Toys Recalled Due to Ingestion Hazard; Risk of Serious Injury or Death; Federal Toy Standard Violation; Sold Exclusively on Amazon by Yiwu Dixikeji Douxiangongsi

July 2, 2025 By The CPSC

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Trane Recalls Gas/Electric Packaged Units Due to Risk of Gas Leak, Fire Hazard

July 2, 2025 By The CPSC

Jeriflyer Pool Drain Covers Recalled Due to Risk of Serious Injury or Death from Entrapment Hazard; Violation of the Virginia Graeme Baker Pool and Spa Safety Act; Sold on Amazon by Junjuanshop

July 2, 2025 By The CPSC

Positec Recalls Electric Corded Chainsaws and Pole Saws Due to Laceration Hazard

July 2, 2025 By The CPSC

Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging

June 27, 2025 By The FDA

Shang Hao Jia, Inc. Issues Allergy Alert on Undeclared Sesame in Danshi Brand Spicy Shredded Tofu

June 25, 2025 By The FDA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging

June 27, 2025 By The FDA

Shang Hao Jia, Inc. Issues Allergy Alert on Undeclared Sesame in Danshi Brand Spicy Shredded Tofu

June 25, 2025 By The FDA

The Coleman Company Recalls Converta Camping Cots and Converta Camping Suspension Stretchers Due to Laceration and Amputation Hazards; Imported by Newell Brands

June 25, 2025 By The CPSC

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Mondelēz Global LLC Conducts U.S. Voluntary Recall of Four Carton Sizes of RITZ Peanut Butter Cracker Sandwiches Due to Labeling Error
  • 509 Recalls Helmets Due to Risk of Head Injury
  • SNLN Party Supply Toys Recalled Due to Ingestion Hazard; Risk of Serious Injury or Death; Federal Toy Standard Violation; Sold Exclusively on Amazon by Yiwu Dixikeji Douxiangongsi
  • Harbor Freight Tools Recalls Predator 2000-Watt Power Stations Due to Shock Hazard
  • DEWALT Recalls Grinder Flap Discs Due to Laceration and Injury Hazards
  • Trane Recalls Gas/Electric Packaged Units Due to Risk of Gas Leak, Fire Hazard
  • Jeriflyer Pool Drain Covers Recalled Due to Risk of Serious Injury or Death from Entrapment Hazard; Violation of the Virginia Graeme Baker Pool and Spa Safety Act; Sold on Amazon by Junjuanshop
  • Positec Recalls Electric Corded Chainsaws and Pole Saws Due to Laceration Hazard
  • Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2025 Altrumedia · Terms of Service · Log in